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Confocal laser scanning microscopyWe assayed fusion events between giant unilamellar vesicles (GUVs) and budded viruses (BVs) of
baculovirus (Autographa californica nucleopolyhedrovirus), the envelopes of which have been labeled with
the ﬂuorescent dye Alexa Fluor 488. This involves observing the intensity of ﬂuorescence emitted from the
lipid bilayer of single GUVs after fusion using laser scanning microscopy. Using this assay system, we found
that fusion between single GUVs and BV envelopes was signiﬁcantly enhanced at around pH 5.0–6.0, which
suggests that: (1) envelope glycoprotein GP64-mediated membrane fusion within the endosome of insect
cells was reproduced in our artiﬁcial system; (2) acidic phospholipids in GUVs are necessary for this fusion,
which are in agreement with the previous results with conventional small liposomes including large
unilamellar vesicles and multilamellar vesicles; and (3) the efﬁciency of fusion is signiﬁcantly affected by
membrane properties that can be modulated by adding cholesterol to GUV lipid bilayers. In addition, the
microscopic observation of BV-fused single GUVs showed that a weak interaction occurred between BVs and
GUVs containing dioleoylphosphatidylserine at pH 6.0–6.5, and components of BV envelopes were unevenly
distributed upon fusion with GUVs containing saturated phospholipid with cholesterol. We further
demonstrated that when the recombinant membrane protein, adrenergic β2 receptor, was expressed on
recombinant BV envelopes, the protein distribution on BV-fused GUVs was also affected by their lipid
contents.Materials, Graduate School of
,Mie514-8507, Japan. Tel.:+81
oto).
gineering, Tokyo Medical and
, Tokyo 101-0062, Japan.
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Giant liposomes, or giant unilamellar vesicles (GUVs), are enclosed
with phospholipid membranes similar to those commonly found in
living organisms. A GUV is typically ∼10–100 µm in diameter, which
is large enough to observe and manipulate using an optical micro-
scope and a micromanipulator [1,2]. Thus, GUVs have been used as
model systems to analyze various kinds of processes involving bio-
membranes and microcompartments, such as the interactions of lipid
membranes with cytoskeletal proteins [3], the reconstitution of
bacteriorhodopsins [4], and the microencapsulation of gene expres-
sion systems [5,6]. It has been considered that an assay based on a
single GUV may help to clarify biochemical properties that can be
missed in the analysis of an ensemble of many conventional smallliposomes [7], and this is known as a single GUV assay. Unsymmetrical
membrane structures have also been visualized on GUVs [8], which
suggests that they may be useful as platforms for the reconstitution of
intricate cell membrane functions.
In addition, GUVs have recently been used to investigate
membrane fusion phenomena such as vesicular transport [9]. Mem-
brane fusion plays an important role in intracellular and intercellular
membrane trafﬁc events, which are usually regulated by speciﬁc
membrane proteins [10,11]. Various types of fusion, not only vesicular
transport but also viral entry, have been studied using conventional
liposomes, whereas GUV assays have only recently become available
to investigate protein properties related to such fusion events [12,13].
In particular, there has been very little use of GUVs to investigate
the fusion properties of enveloped viral particles, which generally
undergo fusion with plasma membranes or low-pH-triggered fusion
with endosomal membranes [10,11]. This prompted us to examine
the fusion events of enveloped viruses with single GUVs microscop-
ically. For this purpose, we chose the baculovirus Autographa
californica nucleopolyhedrovirus (AcNPV) as an enveloped virus,
which is often used to produce recombinant proteins [14]. The AcNPV
is an insect virus with a large circular genome (∼134 kb of DNA) and is
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forms: occluded derived virus (ODV) and budded virus (BV), the latter
of which is easily propagated in a host insect cell culture. On infection,
BVs enter cells via adsorptive endocytosis. First, the envelope
glycoprotein GP64 binds to receptors on the cell surface and then
causes the fusion of BV envelopes with endosomal membranes due to
its fusogenic activities resulting from conformational changes trig-
gered by a low pH within endosomes [15–19]. Such activities are
observed not only in insect cells but also in mammalian cells [20–22],
and thus, baculovirus may be a promising vector for gene therapy
[23]. Recently, it has been reported by Yoshimura et al. [24–26] that
proteoliposomes are able to be prepared by fusing liposomes with
recombinant AcNPV BVs because the BVs can express the desired
recombinant transmembrane protein on their own envelopes. Thus,
adjusting fusion conditions is considered to be important from the
viewpoint of application.
In the present study, we ﬁrst examined the properties of
baculovirus fusion using laser scanning microscopy by mixing single
GUVs with BV envelopes labeled with the ﬂuorescent dye Alexa Fluor
488. Although the cellular receptors for GP64 protein are unclear,
negatively charged phospholipids are likely to play an important role
in entry into mammalian cells [27,28]. Therefore, we prepared GUVs
containing various acidic phospholipids such as dioleoylphosphati-
dylserine (DOPS), dioleoylphosphatidic acid (DOPA) and dioleoylpho-
sphatidylglycerol (DOPG), and examined whether the intensity of
ﬂuorescence emitted from GUV lipid bilayers reﬂected the efﬁciency
of viral fusion induced by the low-pH-triggered GP64 function. Using
this assay, we showed that: (1) the fusion of single GUVs and BV
envelopes was signiﬁcantly promoted in the pH range from 5.0 to 6.0,
which is comparable to the pH that activates GP64 in endosomes; and
(2) GUVs containing DOPS or DOPA underwent more efﬁcient fusion
than those with DOPG. We also observed that cholesterol in GUV lipid
membranes affected the fusion efﬁciency and showed that recombi-
nant transmembrane proteins introduced by recombinant AcNPV BVs
were differently detected on unsaturated/saturated GUVs in correla-
tion with their fusion properties.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium salt (dioleoyl-
phosphatidylserine; DOPS), 1,2-dioleoyl-sn-glycero-3-phosphate
monosodium salt (dioleoylphosphatidic acid; DOPA), 1,2-dioleoyl-sn-
3-phospho-rac-(1-glycerol) sodium salt (dioleoylphosphatidylglycerol;
DOPG), 1,2-dioleoyl-sn-glycero-3-phosphocholine (dioleoylpho-
sphatidylcholine; DOPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-
rac-(1-glycerol) sodium salt (dipalmitoylphosphatidylglycerol;
DPPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (dipalmitoyl-
phosphatidylcholine; DPPC), and cholesterol (Chol) were purchased
from Avanti Polar Lipids (Alabaster, AL). To label viral envelopes,
Alexa Fluor 488 carboxylic acid succinimidyl ester (Alexa Fluor 488-
SE)was purchased fromMolecular Probes (Eugene, OR). SephadexG-
50 (GE Healthcare Bio-Science, Piscataway, NJ) was used in gel
ﬁltration to purify labeled viral particles. Sf-900 II SFM medium was
obtained from Invitrogen (Carlsbad, CA). The other reagents were of
analytical grade.
2.2. GUV preparation
GUVs (liposome suspensions with a total phospholipid concen-
tration of 1 mM)were prepared using the gentle hydration (or natural
swelling) of lipid ﬁlms. Brieﬂy, for each GUV suspension, DOPG/DOPC
(1:1, 3:7, or 1:9), DOPS/DOPC (1:1, 3:7, or 1:9), DOPA/DOPC (1:1, 3:7,
or 1:9), DOPG/DOPC/Chol [5:5:1.1 (corresponding to 10% Chol), 1:1:1
(33% Chol), or 1:1:2 (50% Chol)], or DPPG/DPPC/Chol [5:5:1.1 (10%Chol), 1:1:1 (33% Chol), 5:5:6.7 (40% Chol), or 1:1:2 (50% Chol)]
dissolved in chloroform was placed in a glass micro test tube, and the
solution was evaporated under ﬂowing argon gas until lipid ﬁlms
formed at the bottom. To completely remove chloroform, ﬁlms were
placed in a desiccator in vacuo overnight. Filmswere then hydrated by
adding buffers at various pH values [20 mM CH3COOH/CH3COONa
(pH 3.5–5.5) or 20 mM Na2HPO4/NaH2PO4 (pH 6.0–7.0)], and
incubated for over 12 h at 27 °C to form GUVs spontaneously.
2.3. Preparation of BV envelopes
BVs of AcNPV were harvested as follows: the insect cell line Sf9
(Invitrogen) derived from the fall armyworm Spodoptera frugiperda
was cultured in 10 culture ﬂasks (75 cm2) containing 12 mL of Sf-900
II medium each until they covered ∼80% of the bottom of the ﬂask. A
suspension of AcNPV BVs (BD Bioscience, San Jose, CA) was spread in
each ﬂask at an MOI (multiplicity of infection) of ∼1. Flasks were
incubated at 27 °C for 72 h and then held at 4 °C until the following
procedure was conducted. The culture medium was centrifuged at
1000 ×g for 5 min at 4 °C to precipitate and remove cells. The super-
natant was ultracentrifuged at 100,000 ×g for 1 h at 15 °C (Beckman
L-70 SW28), and the resulting pellet was resuspended in PBS (1 mM
Na2HPO4, 10.5 mM KH2PO4, 140 mM NaCl, 40 mM KCl, pH 6.2).
The suspension was centrifuged at 40,000 ×g for 30 min at 15 °C
(Beckman L-70 SW28) on a sucrose density gradient (10%, 15%, 20%,
25%, and 30% sucrose (wt./vol.) in PBS). Two bands were observed:
the lower contained intact BVs, and the upper contained BV envelopes
without nucleocapsids [24]. Bands were recovered separately, diluted
in PBS, and ultracentrifuged again at 100,000 ×g for 1 h at 15 °C
(Beckman L-70 SW28). The pellets were resuspended in PBS (0.5 mL)
and stored at 4 °C. The amounts of BVs were estimated using a Protein
Assay Kit (BIO-RAD, Hercules, CA).
2.4. Fluorescent labeling of BV envelopes
Labeling was carried out by the conjugation of Alexa Fluor 488-SE
with BV envelopes. For labeling, we chose the upper-band suspension,
since its larger yield and loss of nucleocapsids facilitated the
experimental procedures [24]. A 10-µL aliquot of Alexa Fluor 488-SE
(5 mg/mL in DMSO) was added to 0.5 mL of the suspension, and after
a 2-h incubation at room temperature (RT), labeled BVs were sepa-
rated from unreacted dye by gel ﬁltration at 4 °C, and PBS buffer
containing suspended BVs was exchanged for 10 mM Tris–HCl/
10 mM NaCl (pH 7.5). Under this condition, Alexa Fluor 488-SE
seemed to prefer the α-amino groups of the N-termini of proteins on
BV envelopes to the ε-amino groups of the proteins and amino groups
of phosphatidylserine of BVs because it reacts with nonprotonated
aliphatic amine groups. Fractions containing labeled BV envelopes
were detected using a spectroﬂuorometer at excitation and emission
wavelengths of 495 and 519 nm, respectively. Since the yields of
labeled BV envelopes ﬂuctuated in each run of preparation and
labeling, aliquots obtained from the same BV envelope specimenwere
used in each series of microscopic observations described below.
2.5. Fusion assay of GUVs and BV envelopes
Samples containing GUVs were observed by confocal laser
scanning microscopy (LSM) as described previously [29]. An aliquot
of the GUV suspension at a given pHwas mixed with an equal volume
of labeled BV envelope suspension and incubated for over 30 min at
RT. The resultant pH of eachmixturewas the same as that of the initial
buffer of the GUV suspension. A portion of the mixture (∼10 µL) was
gently placed on a glass coverslip with a silicone rubber spacer
(0.1 mm thick) and covered with another coverslip. LSM observation
of individual GUVs fused with BV envelopes was performed using an
OLYMPUS confocal laser scanning microscope (FLUOVIEW FV1000)
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laser (488 nm). The same machine parameters optimally adjusted for
the excitation and detection of Alexa Fluor 488 were used to obtain
ﬂuorescence images in every assay. LSM images of 20 or 30 GUVs
fused with BV envelopes were obtained at each pH. To evaluate the
fusion efﬁciency, the intensities of Alexa ﬂuorescence emitted by
single GUV membranes were determined from their images using
image-analysis software (AQUACOSMOS 2.5; Hamamatsu), as de-
scribed in Fig. 1. GUVs with diameters of ∼10 µm were used for the
assay.
2.6. Preparation and LSM observation of GUVs fused with recombinant
AcNPV BV envelopes
The clone of cDNA of human adrenergic β2 receptor (ADRB2,
GenBank accession number NM_000024.3) was obtained from
Missouri S&T cDNA Resource Center (Rolla, MO). The recombinant
AcNPVwas prepared according to the previous report [26]. The AcNPV
BV envelopes were recovered from the Sf9 cell culture media as
mentioned above. Using Western blot analysis, that ADRB2 protein
was expressed with the AcNPV BV envelopes was veriﬁed as shown in
Supplementary data 1. The GUV suspensions [DOPG/DOPC/Chol =
1:1:0 (0% Chol), 1:1:2 (50% Chol) or DPPG/DPPC/Chol=5:5:1.1 (10%
Chol), 1:1:2 (50% Chol); total phospholipid concentration of 1 mM] in
20 mM CH3COOH/CH3COONa (pH 4.5) buffer were added to 9 µg of
ADRB2 or wild-type AcNPV BVs and were incubated at 27 °C for 1 h.
The suspension was centrifuged at 18,000 ×g for 5 min at 15 °C, and
then resulting pellet was resuspended in 100 µL of 10 mM Tris–HCl/
10 mM NaCl (pH 7.5). This GUV solution was mixed with 1 µL of
10 µM BODIPY630/650-conjugated β2 adrenaline receptor agonist
(CellAura Technologies Ltd., Nottingham, UK), and was incubated at
27 °C for 30 min. The suspension was centrifuged at 18,000 ×g for
5 min at 15 °C, and the resulting pellet was resuspended in 100 µL of
10 mM Tris–HCl/10 mM NaCl (pH 7.5). The samples were observed
using a Carl Zeiss confocal laser scanningmicroscope (LSM 510META;
Carl Zeiss, Oberkochen, Germany) equipped with an oil-immersion
objective lens (63×) and a helium neon laser (633 nm).Fig. 1. Evaluation of ﬂuorescence intensity of single GUVs. A typical LMS image is
presented. Intensity was estimated using the indicated formula in all measurements:
FIGUV is the intensity of the overall Alexa Fluor 488 ﬂuorescence emitted by the entire
cross-section of a single GUV; FIbackground is the ﬂuorescence intensity of the
background of the same area as the corresponding GUV; and ΔFIfusion is the difference
between the above values, which reﬂects the extent of fusion between BV envelopes
and individual GUVs.3. Results
3.1. Fusion of BV envelopes depends on the acidic phospholipid
composition of GUVs
We carried out all fusion assays using Alexa Fluor 488-SE as a
ﬂuorescent dye because its ﬂuorescence is stable over a wide range of
pH values [30]. We ﬁrst surveyed GUVs consisting of acidic/neutral
phospholipids such as DOPG/DOPC (molar ratio of 1:1), DOPS/DOPC
(1:1), and DOPA/DOPC (1:1) mixed with Alexa-labeled BV envelopes
in low- and neutral-pH conditions, to conﬁrm the detectability of
GP64-mediated fusogenic activity promoted by weakly acidic pH at a
single-liposome level. Figs. 2A and B show typical confocal images of
ﬂuorescent GUVs at pH 5.0 and 7.0, respectively. When BV envelopes
fuse with GUVs, ﬂuorescent dye-labeled proteins are diffusing
laterally over the lipid membranes, leading to uniform ﬂuorescence
emission from the GUV contours. In all cases, the ﬂuorescence
intensity at pH 5.0 was greater than that at pH 7.0, indicating that
GUVs were fused with BV envelopes due to the low-pH-triggered
activity of GP64, as in BV infection through adsorptive endocytosis
[15–19]. No fusion was observed with acidic phospholipid-free GUVs
(data not shown). We obtained average ﬂuorescence intensities from
LSM images by analyzing approximately 30 single GUVs at each pH
and lipid composition, according to the formula in Fig. 1. As shown in
Figs. 2C and D, GUVs with DOPS or DOPA had higher ﬂuorescence
intensity than those with DOPG at pH 5.0. The difference between 50%
DOPG and 50% DOPS was statistically signiﬁcant (Pb0.001). The
ﬂuorescence intensity of GUVs decreased at both pH values with a
decrease in the content of acidic phospholipids (from 50 down to
10%). In particular, only a few ﬂuorescent GUVs were observed with
10% acidic lipids, except for 10% DOPA at pH 5.0, suggesting that DOPA
could interact most effectively with GP64-mediated fusion between
GUVs and BVs among the three acidic phospholipids.
3.2. pH dependence of fusion between GUVs and BV envelopes
We conducted LSM observations with Alexa-labeled BV enve-
lopes and GUVs composed of DOPG/DOPC (1:1) and DOPS/DOPC
(1:1) in the pH range of 3.5 to 7.0. Fig. 3 shows the ﬂuorescence
intensities of Alexa as a function of pH. In both cases, there was a
somewhat steep increase in ﬂuorescence intensity around pH 5.0–
5.5 for DOPG/DOPC GUVs or around pH 5.0–6.0 for DOPS/DOPC
GUVs. In the pH range of 6.0–6.5, DOPS/DOPC GUVs had slightly
higher ﬂuorescence intensities than at pH 7.0. This pH-dependence
of fusion activity seems to be related to the physiological function
of GP64, i.e., adsorption to extracellular membrane surfaces, as
discussed in the following section. The steep increases in both
curves in the pH range of 5.0–6.0 suggest that fusion is triggered by
a decrease in pH to the value that speciﬁcally activates GP64. These
curves are similar to those with large unilamellar vesicles (LUVs)
and multilamellar vesicles (MLVs), but the pH range is slightly
higher [24]: AcNPV BVs started to fuse with PS/PC liposomes below
pH 5.0. We observed another difference in fusion activity between
DOPG and DOPS: the ﬂuorescence intensities of DOPS/DOPC
GUVs were greater than those with DOPG/DOPC GUVs over a
wide range of pH (Fig. 3). In particular, at around pH 5.0 and below,
the ﬂuorescence intensities for DOPG/DOPC GUVs were almost
constant, whereas those for DOPS/DOPC GUVs gradually increased,
most likely because the pKa of phosphatidylserine is in the range
of 4.0–4.5, resulting in the neutralization of negatively charged
carboxyl groups [31]. The results of in vitro experiments on GUVs
imply that AcNPV BVs prefer to interact with DOPS rather than
DOPG over the entire pH range. The effect of the buffer type on the
pH-dependent changes in ﬂuorescence intensity was negligible,
since similar results were obtained when we used different kinds
of buffer.
Fig. 3. pH dependence of fusion between BV envelopes and single GUVs: DOPG/DOPC at
1:1, (■); DOPS/DOPC at 1:1, (♦). Each graph shows the average values (ΔFIfusion) plus
SD obtained by evaluating ﬂuorescence intensities of 20 single GUVs at each pH.
Fig. 2. Fusion assay for Alexa-labeled BV envelopes and single GUVs composed of
different acidic phospholipids. GUVs [DOPG/DOPC, DOPS/DOPC, and DOPA/DOPC at
molar ratios of 1:1 (corresponding to 50% acidic phospholipid), 3:7 (30%), and 1:9
(10%)] were examined under weakly acidic (pH 5.0; A, C) and neutral (pH 7.0; B, D)
conditions. Typical LSM ﬂuorescent images of single GUVs fused with BV envelopes are
presented at pH 5.0 (A) and pH 7.0 (B). Bar: 10 µm. The average ﬂuorescence intensity
values (ΔFIfusion) in arbitrary units (au) were obtained by evaluating 30 single GUVs at
pH 5.0 (C) and 7.0 (D). Error bars indicate the standard deviation (SD). GUVs containing
50% DOPG and 50% DOPSwere signiﬁcantly different [Pb0.001,Welch's test (n=30)] at
pH 5.0.
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ﬂuorescence microscopy; through this observation, however, fusion
could not be completely discriminated from the hemifusion and
association of BVs with GUVs or the transfer of ﬂuorescent com-
ponents of BVs to GUV membranes, which likely appeared in part
concurrently with fusion. To ascertain the indication of the fusion by
another way, we observed samples of GUVs (DOPG/DOPC=1:1)
mixed with BVs at pH 7.0 and 4.5 using transmission electron
microcopy (TEM; Supplementary data 2). GUVs were not associated
with BVs at pH 7.0, and their shapes were as intact as those without
BVs. In contrast, some membrane surfaces of the latter GUVs assumed
omega shapes, which characterized fusion between membranes andviral envelopes as presented by Kanaseki et al. [32], although
associated or hemifused BVs on to GUVs were also seen. Therefore,
the ﬂuorescence intensities obtained heremostly reﬂected occurrence
of fusion between BVs and GUVs.
3.3. Cholesterol effect on the fusion of GUVs and BV envelopes
Lipid species and their proportions in GUV membranes apparently
inﬂuenced the fusion properties of BV envelopes. Therefore, we next
examined the effect of cholesterol on the fusion behavior in the assay
system. Fig. 4 shows typical images and fusion curves of Alexa-labeled
BV envelopes and single GUVs consisting of the unsaturated phos-
pholipid DOPG/DOPC or saturated DPPG/DPPC and cholesterol.
Cholesterol generally affects membrane ﬂuidity: membranes of unsat-
urated lipids, which are in a liquid–crystalline state at RT, become
more solid as the cholesterol content increases, while those of
saturated lipids, which are in a gel-like state at RT, become more ﬂuid
[33]. Although GUVs can never be generated from solid lipid ﬁlms of
saturated phospholipids at RT using the gentle hydration method
[34], we obtained GUVs by adding cholesterol to saturated lipid ﬁlms.
Based on a comparison of LSM images of single GUVs in the
absence and presence of 50% cholesterol at pH 4.5, DOPG/DOPC
GUV without cholesterol was more ﬂuorescent than that containing
cholesterol (Fig. 4A), whereas a DPPG/DPPC GUV exhibited the
opposite trend (Fig. 4B). Although DOPG/DOPC GUVs without
cholesterol and DPPG/DPPC GUVs with 50% cholesterol both
efﬁciently fused with BV envelopes, the details were different: the
former emitted strong ﬂuorescence homogeneously from the mem-
branes, and the latter typically showed spotty ﬂuorescence on the
membranes, implying that some fractions of BV envelopes were
distributed heterogeneously on GUV membranes after fusion. Differ-
ences were also observed in the pH dependence of fusion (Figs. 4C and
D). In the case of DOPG/DOPC GUVs, an increase in the cholesterol
content inhibited fusion with BV envelopes under pH conditions
below 5.5, and the sigmoidal shape of the curves disappeared at 50%
cholesterol. In contrast, an increase in cholesterol enhanced the
ﬂuorescence intensities of DPPG/DPPC GUVs under pH conditions
below 6.5. However, the curves for both 40 and 50% cholesterol
increased linearly with decreasing pH. The intensities of saturated
GUVs were less than those of unsaturated GUVs.
Recently, we have reported that recombinant AcNPV BVs that
expressed recombinant transmembrane proteins such as G protein-
coupled receptors (GPCRs) on their own envelopes were fused with
liposomes and then proteoliposomes could be obtained [24–26]. Here,
we further presented an experimental example that the lipid content
of GUVs affected the distribution of the GPCR proteins (adrenergic β2
receptor, ADRB2) introduced by GUV-fused recombinant BV enve-
lopes. Fig. 5 shows typical LSM images of GUVs fused with ADRB2
recombinant AcNPV BVs, in which ADRB2 protein was detected by
Fig. 4. Effects of cholesterol on the fusion of BV envelopes and GUVs. GUVs containing unsaturated phospholipids [DOPG/DOPC at a molar ratio of 1:1 (Chol 0%) and DOPG/DOPC/
cholesterol at 5:5:1.1 (Chol 10%), 1:1:1 (Chol 33%), and 1:1:2 (Chol 50%)] and saturated phospholipids [DPPG/DPPC/cholesterol at molar ratios of 5:5:1.1 (Chol 10%), 1:1:1 (Chol
33%), 5:5:6.7 (Chol 40%), and 1:1:2 (Chol 50%)] were examined at each pH. Typical LSM images (pH 4.5) of GUVs with DOPG/DOPC (A) and GUVs with DPPG/DPPC (B) obtained in
the presence of 0%, 10%, or 50% cholesterol in their bilayers are presented (left, Alexa Fluor 488; right, DIC). Bar: 10 µm. Average ﬂuorescence intensities (ΔFIfusion) of single GUVs of
DOPG/DOPC with cholesterol [0% (blue, ♦), 10% (green, ■), 33% (orange, ▲), 50% (pink,●)] and of DPPG/DPPC with cholesterol [10% (blue, ♦), 33% (green,■), 40% (orange,▲), 50%
(pink, ●)] are shown in C and D, respectively. Average values were obtained by evaluating the ﬂuorescence intensities of 20 single GUVs at each pH. Error bars indicate SD.
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manner to that observed in Fig. 4, the ﬂuorescence signal from
unsaturated (DOPG/DOPC) GUVs was reduced in the presence of
cholesterol, whereas that from saturated (DPPG/DPPC) GUVs was
detected more strongly with the higher content of cholesterol;
however, ADRB2 was not detected evenly on the saturated GUVs
with 50% cholesterol.Fig. 5. Fusion of GUVs and recombinant AcNPV BVs with adrenergic β2 receptor protein was
[DOPG/DOPC at a molar ratio of 1:1 (Chol 0%) and DOPG/DOPC/cholesterol at 1:1:2 (Chol 50
(Chol 10%) and 1:1:2 (Chol 50%)] (B) were examined and the typical LSM ﬂuorescent (left) an
detected using a BODIPY630/650-conjugated agonist against the receptor. No ﬂuorescence4. Discussion
In the present study, we assayed the fusion of enveloped viruses
with GUVs by the direct microscopic observation of single GUVs. We
chose AcNPV BV as a model virus for several reasons. First, it is quite
harmless to humans and other organisms except its host insects, and
sufﬁcient amounts of its envelope can be easily prepared from a virus-modulated by changing the lipid content. GUVs containing unsaturated phospholipids
%)] (A) and saturated phospholipids [DPPG/DPPC/cholesterol at molar ratios of 5:5:1.1
d DIC (right) images are shown. Localization of adrenergic β2 receptor on the GUVs was
was detected on GUVs fused with wild-type AcNPV BVs (C). Bar: 10 µm.
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genome has been fully sequenced and genetically engineered for
the production of recombinant proteins and to facilitate gene delivery
[14]. Third, for the use of intact membrane-bound proteins, a new
technology to reconstitute recombinant membrane protein from its
envelope to conventional liposomes (called recombinant proteolipo-
somes) has been developed [24–26], and fusion between the envelope
and liposomes is a requisite step. Thus, studies on the mechanism
of fusion of AcNPV BVs with GUVs are not only important from a
basic aspect but may also be useful for expanding its application in
biotechnology.
In general, enveloped viruses including AcNPV BV that infect host
cells via endocytosis have speciﬁc target molecules as receptors on
hosts and possess envelope fusion glycoproteins, which are activated
by exposure to a low-pH milieu [10,11]. GP64 is the envelope fusion
glycoprotein of AcNPV BV and is sufﬁcient for the binding and fusion
required for infection [15]. It has been presumed that BVs enter both
insect and mammalian cells through receptor-mediated endocytosis,
without the identiﬁcation of any speciﬁc receptors [20]. Recently, Tani
et al. [28] reported that negatively charged phospholipids are
important for the entry of BVs into mammalian cells. Therefore, we
prepared GUVs consisting of DOPG/DOPC, DOPS/DOPC, and DOPA/
DOPC to conﬁrm that the fusion of individual GUVs and BV envelopes
depended on low pH and the dose of acidic phospholipid (Fig. 2).
Consequently, the dependence of BV–GUV fusion on pH and
composition of acidic phospholipid was observed. Similarly, human
immunodeﬁciency virus type 1 (HIV-1) exhibits the fusion trend that
depends on pH reduction and acidic phospholipid content [35]. Our
results regarding the efﬁcacy of DOPA, DOPS, or DOPG at inducing
fusion were consistent with previous data on the inhibitory effects of
these phospholipids on AcNPV BV entry [28]. Analyses of the lipid
composition of Sf9 cell membranes indicated that phosphatidylserine
(PS) is themajor acidic phospholipid, although its actual level remains
controversial [36,37], suggesting that PS is a plausible candidate for the
GP64 target. BVs fused with DOPS/DOPC GUVs signiﬁcantly more
efﬁciently than DOPG/DOPC GUVs (Fig. 2C). When we closely
analyzed the pH dependence of fusion between BV envelopes and
GUVs, the fusion curves ofDOPG/DOPCandDOPS/DOPCGUVsdiffered
at pH below 5.5 and above 6.0 (Fig. 3). The curve of DOPG/DOPC GUVs
showed a single steep increase around pH 5.0–5.5, which probably
reﬂects the fusogenic activity of GP64 induced by the corresponding
pH range [15,16,19]. In contrast, the curve of DOPS/DOPC GUVs
exhibited a relatively monotonic increase along with a decrease in pH.
Therefore, it is speculated that the curvemight be a composite of three
types of interactions that can be attributed to (1) the reduction of
electrostatic repulsion between GUV bilayers and BV envelopes due to
protonation of the PS carboxylic group in GUVs and possibly BVs
around pH 3.5–4.5 [31], (2) the fusogenic activity of GP64 around pH
5.0–6.0, and (3) the binding afﬁnity of BV to PS around pH 6.0–6.5.
Interestingly, the pH of insect hemolymph falls within the moderate
pH range (∼6.5) [38]. In a previous study, Fukushima et al. [24] showed
that AcNPV BV envelopes and PS-containing conventional liposomes
(LUVs and MLVs) were fused below pH 5.0 using an R18 dequenching
assay. In that case, fusion of BV envelopes and liposomes could not be
detected above pH 5.0. The present result obtained using GUVs was
nearly the same as with the conventional liposomes, LUVs, and MLVs
except (3). We observed an increase in ﬂuorescence intensity at pH
5.0–6.0 and slightly stronger ﬂuorescence at pH 6.0–6.5 when using
DOPS/DOPC GUVs. These observations implied that PS may preferably
interact with BVs, possibly GP64, on membrane surfaces in vivo. If the
results from GUVs were further compared with conventional lipo-
somes, the behavior of AcNPV BV envelopes under moderately weak
acidic condition could become clearer.
In addition, the ﬁdelity of this fusion assay should be mentioned
because membrane fusion is difﬁcult to completely discriminate from
hemifusion and association when using the assay based on lipidmixing. Here, we conducted the TEM observation on GUVs (DOPG/
DOPC = 1:1) mixed with BVs at both neutral and acidic pH
(Supplementary data 2): GUVs assumed intact shapes at pH 7.0
even in the presence of BVs. In contrast, BV envelopes bound to GUVs,
resulting in full fusion at pH 4.5, but BVs attached on the surface of
GUVs were also observed. Therefore, it is noted that lowering pH may
enhance fusion and incomplete phenomena before fusion in parallel
because activation of GP64 under an acidic pH condition may induce
conformational changes of the fusogenic protein leading to an
increase in the afﬁnity of BVs to lipid membranes, and so the results
of the fusion assay based on Alexa-labeled BVs may basically involve
the latter phenomena. On the other hand, judging from the typical
TEM images and our previous study [24], activity of GP64 is
suppressed under a neutral pH condition. Generally, membrane
fusion can more efﬁciently bring labeled components to the target
membranes. Although the present result involves membrane fusion
accompanied with the incomplete fusion phenomena, we believe that
this assay can mostly show the fusion properties of BVs and GUVs.
However, it is intriguing to examine the fraction of BVs that can fully
fuse with GUVs because it may be directly related to the efﬁciency of
the above proteoliposome reconstitution.
We also examined the effects of cholesterol on the properties of BV
envelope fusion (Fig. 4). It is well known that cholesterol modulates
lipid membrane ﬂuidity: the addition of cholesterol makes gel-like
lipid bilayers more ﬂuid and liquid–crystalline lipid bilayers more
solid [33] and have the myriad effects on viral membrane fusion [39].
We used GUVs containing unsaturated phospholipid DOPG/DOPC
(liquid–crystalline phase at RT) and saturated phospholipid DPPG/
DPPC (solid phase at RT) with various cholesterol contents. An
increase in the cholesterol content hindered fusion in DOPG/DOPC
GUVs and enhanced fusion in DPPG/DPPC GUVs. The infectivities of
some kinds of enveloped viruses are known to be modulated directly
by the speciﬁc interactions of envelope proteins with cholesterol [40],
but this does not seem to be the casewith AcNPV BV, since Sf9 cells are
very deﬁcient in cholesterol [36,37]. However, differences in the
cholesterol content of the cell membrane may be involved in tissue-
speciﬁc susceptibility to BV infection in vivo. Our assay system using
GUVs with artiﬁcially controlled lipid compositions suggested a
simple rule that viral fusion efﬁciency may depend on membrane
properties; i.e., host membranes fuse more readily as they become
more ﬂuid. Interestingly, we found that the LSM images of individual
GUVs (Figs. 4A and B) showed different patterns: ﬂuorescence was
emitted evenly from membranes of unsaturated GUVs but unevenly
from saturated ones. The spotty pattern on the contour of a GUV
(1:1:2 DPPG/DPPC/Chol; Fig. 4B) indicates that the membrane
components of GUVs and AcNPV BVs do not mix homogeneously
upon fusion. Increasing cholesterol enhanced fusion of AcNPV BVs and
DPPG/DPPC GUVs, while it hindered homogeneous diffusion of viral
envelope components over GUV membranes. This trend was
reproduced when recombinant transmembrane receptor protein
(ADRB2) introduced by AcNPV BV–GUV fusion was visualized
using ﬂuorescent dye-conjugated agonist reagents (Fig. 5). In the
LSM image (Fig. 5B) ADRB2 did not appear spread over GUV
membranes. Probably, when thinking of preparing giant proteolipo-
somes using recombinant baculovirus AcNPV, the lipid content
of GUVs is signiﬁcant in localization of a reconstituted protein on
their membrane. Further investigation on this dependence seems
important.
We have demonstrated that assays based on confocal microscopic
observations of single GUVs are useful for investigating the effects
of pH and lipid composition on AcNPV BV envelope fusion prop-
erties. The result of the fusion assay is almost in agreement with
that obtained with conventional liposomes. In addition, by taking
advantage of the large size of GUVs, we found a weak virus–liposome
membrane interaction in a stage before fusion and an uneven
distribution of components of viral envelopes on GUV membranes.
1631K. Kamiya et al. / Biochimica et Biophysica Acta 1798 (2010) 1625–1631If the feature is promoted that local structure of membranes where
fusion has occurred can be observed microscopically on the level of
individual GUVs, this assay may contribute to understanding
biological membrane interactions including fusion of enveloped
viruses.
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